{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:11:09Z","timestamp":1789942269519,"version":"4.0.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In the steady state, tumors harbor several populations of dendritic cells (DCs) and myeloid cells that are key regulators of the intratumoral immune environment. Among these cells, migratory CD103+ cross-presenting DCs are thought to be critical for tumor-specific CTL responses and tumor resistance. However, it is unclear whether this prominent role also extends to immunotherapy. We used a murine orthotopic mammary tumor model, as well as Clec9A\u2013diphtheria toxin receptor mice that can be depleted of the specialized cross-presenting CD8\u03b1+ and CD103+ DC1 subsets, to investigate the role of these DCs in immunotherapy. Treatment with monosodium urate crystals and mycobacteria at the tumor site delayed tumor growth and required DC1s for efficacy. In contrast, treatment with poly I:C was equally effective regardless of DC1 depletion. Neither treatment affected myeloid-derived suppressor cell numbers in the spleen or tumor. Similar experiments using subcutaneous B16 melanoma tumors in BATF3-knockout mice confirmed that CD103+ DCs were not necessary for successful poly I:C immunotherapy. Nevertheless, adaptive immune responses were essential for the response to poly I:C, because mice depleted of CD8+ T cells or all DC subsets were unable to delay tumor growth. In vivo experiments showed that DC1 and DC2 subsets were able to take up tumor Ags, with DC2s making up the larger proportion of lymph node DCs carrying tumor material. Both DC subsets were able to cross-present OVA to OT-I T cells in vitro. Thus, immunotherapy with poly I:C enables multiple DC subsets to cross-present tumor Ag for effective antitumor immune responses.<\/jats:p>","DOI":"10.4049\/jimmunol.1701593","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T16:50:10Z","timestamp":1520268610000},"page":"2978-2986","source":"Crossref","is-referenced-by-count":24,"title":["Clec9A+ Dendritic Cells Are Not Essential for Antitumor CD8+ T Cell Responses Induced by Poly I:C Immunotherapy"],"prefix":"10.1093","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-1143","authenticated-orcid":false,"given":"Connie B","family":"Gilfillan","sequence":"first","affiliation":[{"name":"Malaghan Institute of Medical Research , Wellington 6021,","place":["New Zealand"]},{"name":"University of Otago , Wellington, Wellington 6021,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Malaghan Institute of Medical Research , Wellington 6021,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Baey","sequence":"additional","affiliation":[{"name":"Malaghan Institute of Medical Research , Wellington 6021,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn J","family":"Hyde","sequence":"additional","affiliation":[{"name":"Malaghan Institute of Medical Research , Wellington 6021,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5336-6530","authenticated-orcid":false,"given":"Jianping","family":"Yang","sequence":"additional","affiliation":[{"name":"Malaghan Institute of Medical Research , Wellington 6021,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-6541","authenticated-orcid":false,"given":"Christiane","family":"Ruedl","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Nanyang Technological University , Singapore 637551,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5835-8230","authenticated-orcid":false,"given":"Franca","family":"Ronchese","sequence":"additional","affiliation":[{"name":"Malaghan Institute of Medical Research , Wellington 6021,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,15]]},"reference":[{"key":"2025030610143241900_r1","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00262-012-1291-8","article-title":"Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis","volume":"61","author":"Rich","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030610143241900_r2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"2025030610143241900_r3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"2025030610143241900_r4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"2025030610143241900_r5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"2025030610143241900_r6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fimmu.2012.00214","article-title":"Expression of XCR1 characterizes the Batf3-dependent lineage of dendritic cells capable of antigen cross-presentation","volume":"3","author":"Bachem","year":"2012","journal-title":"Front. Immunol."},{"key":"2025030610143241900_r7","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1073\/pnas.0601956103","article-title":"The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture","volume":"103","author":"Schnorrer","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030610143241900_r8","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1126\/science.1087576","article-title":"Epidermal viral immunity induced by CD8\u03b1+ dendritic cells but not by Langerhans cells","volume":"301","author":"Allan","year":"2003","journal-title":"Science"},{"key":"2025030610143241900_r9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20091627","article-title":"Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells","volume":"207","author":"Edelson","year":"2010","journal-title":"J. Exp. Med."},{"key":"2025030610143241900_r10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2012.03.009","article-title":"The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments","volume":"36","author":"Zhang","year":"2012","journal-title":"Immunity"},{"key":"2025030610143241900_r11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2012.03.008","article-title":"F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells","volume":"36","author":"Ahrens","year":"2012","journal-title":"Immunity"},{"key":"2025030610143241900_r12","doi-asserted-by":"crossref","first-page":"e1019198","DOI":"10.1080\/2162402X.2015.1019198","article-title":"Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103\u2212 and XCR1+CD103+ dendritic cells","volume":"4","author":"Wylie","year":"2015","journal-title":"Oncoimmunology"},{"key":"2025030610143241900_r13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","article-title":"Robust anti-viral immunity requires multiple distinct T cell\u2013dendritic cell interactions","volume":"162","author":"Eickhoff","year":"2015","journal-title":"Cell"},{"key":"2025030610143241900_r14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.20020295","article-title":"Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(\u2212) dendritic cells in vivo","volume":"196","author":"den Haan","year":"2002","journal-title":"J. Exp. Med."},{"key":"2025030610143241900_r15","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.20110538","article-title":"CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen","volume":"208","author":"Desch","year":"2011","journal-title":"J. Exp. Med."},{"key":"2025030610143241900_r16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","article-title":"Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells","volume":"38","author":"Ma","year":"2013","journal-title":"Immunity"},{"key":"2025030610143241900_r17","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.1301135","article-title":"Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents","volume":"191","author":"Kuhn","year":"2013","journal-title":"J. Immunol."},{"key":"2025030610143241900_r18","doi-asserted-by":"crossref","first-page":"20377","DOI":"10.1073\/pnas.0910295106","article-title":"Different cross-presentation pathways in steady-state and inflammatory dendritic cells","volume":"106","author":"Segura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030610143241900_r19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fimmu.2015.00584","article-title":"Monocyte-derived dendritic cells are essential for CD8(+) T cell activation and antitumor responses after local immunotherapy","volume":"6","author":"Kuhn","year":"2015","journal-title":"Front. Immunol."},{"key":"2025030610143241900_r20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-5-10","article-title":"Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models","volume":"5","author":"Zhu","year":"2007","journal-title":"J. Transl. Med."},{"key":"2025030610143241900_r21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4049\/jimmunol.1201171","article-title":"Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria","volume":"189","author":"Piva","year":"2012","journal-title":"J. Immunol."},{"key":"2025030610143241900_r22","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J. Immunol."},{"key":"2025030610143241900_r23","doi-asserted-by":"crossref","first-page":"e17515","DOI":"10.1371\/journal.pone.0017515","article-title":"Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells","volume":"6","author":"Ataera","year":"2011","journal-title":"PLoS One"},{"key":"2025030610143241900_r24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(24)37005-3","article-title":"Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins","volume":"283","author":"Getting","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025030610143241900_r25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-015-3508-y","article-title":"Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer","volume":"153","author":"Forghani","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"2025030610143241900_r26","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"2025030610143241900_r27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11531","article-title":"Compensatory dendritic cell development mediated by BATF\u2013IRF interactions","volume":"490","author":"Tussiwand","year":"2012","journal-title":"Nature"},{"key":"2025030610143241900_r28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/eji.200940153","article-title":"CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor","volume":"40","author":"McDonnell","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"2025030610143241900_r29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cell.2010.09.039","article-title":"Microbial stimulation fully differentiates monocytes to DC-SIGN\/CD209(+) dendritic cells for immune T cell areas","volume":"143","author":"Cheong","year":"2010","journal-title":"Cell"},{"key":"2025030610143241900_r30","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1084\/jem.20091181","article-title":"Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells","volume":"206","author":"McCartney","year":"2009","journal-title":"J. Exp. Med."},{"key":"2025030610143241900_r31","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.4049\/jimmunol.176.8.4682","article-title":"Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming","volume":"176","author":"Le Bon","year":"2006","journal-title":"J. Immunol."},{"key":"2025030610143241900_r32","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.4049\/jimmunol.181.11.7670","article-title":"Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha\/beta","volume":"181","author":"Ngoi","year":"2008","journal-title":"J. Immunol."},{"key":"2025030610143241900_r33","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.4049\/jimmunol.0903201","article-title":"Cutting edge: polyinosinic:polycytidylic acid boosts the generation of memory CD8 T cells through melanoma differentiation-associated protein 5 expressed in stromal cells","volume":"184","author":"Wang","year":"2010","journal-title":"J. Immunol."},{"key":"2025030610143241900_r34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"key":"2025030610143241900_r35","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1038\/ncomms5674","article-title":"Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction","volume":"5","author":"Desch","year":"2014","journal-title":"Nat. Commun."},{"key":"2025030610143241900_r36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fimmu.2014.00342","article-title":"Pattern recognition and signaling mechanisms of RIG-I and MDA5","volume":"5","author":"Reikine","year":"2014","journal-title":"Front. Immunol."},{"key":"2025030610143241900_r37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ni.2370","article-title":"Deciphering the transcriptional network of the dendritic cell lineage","volume":"13","author":"Miller","year":"2012","journal-title":"Nat. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/200\/8\/2978\/62232300\/ji1701593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/200\/8\/2978\/62232300\/ji1701593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T10:34:37Z","timestamp":1741257277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/200\/8\/2978\/7966176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,4,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1701593","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,4]]}}}